Answers are grounded in this paper and cite their sources.
Background: Patients with acute lymphoblastic leukemia (ALL) are at risk for hyperglycemia due to asparaginase, glucocorticoids, and possible underlying predisposition for glucose intolerance. The use of metformin in pediatric oncology patients is not yet widespread; however, it may be used to control blood glucose levels. Observation: We report a young adult with T-cell ALL in maintenance chemotherapy who developed hemolysis 2 weeks after starting metformin, with resolution upon cessation of metformin. Conclusions: We present this case to increase awareness of metformin-related hemolysis, review the literature, and discuss possible mechanisms for this adverse event.
No takes yet. Share an insight, caveat, or question.
Callas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: